DiviDrip · XFOR

XFOR — X4 Pharmaceuticals, Inc.

XFOR is X4 Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $4.04. Market cap: $401M. Capital Quality Rank: 4/100 — Systemic risk.

Stock snapshot

Price$4.04
Market cap$401M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)4 / 100 · Systemic risk
ROIC (TTM)-150.8%
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About XFOR

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

Listed2017Employees45HQBoston, MASectorHealthcareWebsitex4pharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside XFOR. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is XFOR's current stock price?

XFOR (X4 Pharmaceuticals, Inc.) is currently trading at $4.04.

Does XFOR pay a dividend?

XFOR (X4 Pharmaceuticals, Inc.) does not currently pay a regular dividend.

What is XFOR's Capital Quality Rank?

XFOR has a Capital Quality Rank of 4/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track XFOR in DiviDrip

Add XFOR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow